Genomic insights into the 2022–2023 Vibrio cholerae outbreak in Malawi

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was funded by the UK National Institute for Health and Care Research (NIHR) Global Health Research Group on Gastrointestinal Infections (grant number: NIHR133066) using UK Aid from the UK Government to support global health research; and the Bill and Melinda Gates Foundation (Grant number: Investment number: INV-046917). N.A.C. is an NIHR Senior Investigator (NIHR203756). N.A.C., D.H., and K.C.J. are affiliated with the NIHR Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool, a partnership with the UK Health Security Agency (UKHSA), in collaboration with the University of Warwick. The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication. The authors did not receive any financial support or other forms of reward related to the development of the manuscript. Therefore, the findings and conclusions in this report are those of the authors and do not necessarily represent the formal position of the funders. The views expressed are those of the author(s) and not necessarily those of the NIHR, the Department of Health and Social Care or the UK Health Security Agency or the UK government.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This work was conducted according to the guidelines of the Declaration of Helsinki and was approved by the National Health Sciences Research Committee, Lilongwe, Malawi (Protocol #867) and the Research Ethics Committee of the University of Liverpool, Liverpool, UK (000490) under the Diarrhoea Surveillance study, and the College of Medicine Ethics Committee (COMREC, Protocol #P.10/22/3790) under the NIHR Global Health Research Group on Gastrointestinal Infections: Facilitating the Introduction and Evaluation of Vaccines for Enteric Diseases in Children in Eastern and Southern sub-Saharan Africa study.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes